Neurology Topics
RSSArticles
-
Health Systems Start Transition to New Approach for Treating Ischemic Stroke
Alteplase has been a mainstay to treat ischemic stroke. When given within hours of an episode, evidence has shown the clot-busting medication can improve outcomes. But what if there was a drug that could deliver similar, and possibly even better, outcomes for a subset of stroke patients without some of the logistical hurdles associated with alteplase?
-
Updated Tactics for Parkinson’s Disease Study Recruitment
Remote, decentralized studies allow for the recruitment of large, geographically dispersed cohorts from a single location. In considering whether to use a decentralized design or to include remote assessments, the research team must determine if these methods can adequately answer the question under study.
-
Few People with Limited English Proficiency Participate in Stroke Studies
Rather than making the IRB processes more difficult for researchers who wish to include underrepresented populations in their study, IRBs should work with researchers to overcome obstacles.
-
Cardiovascular Problems Could Affect Cognition Later in Life
Young patients with high blood pressure and obesity were more likely to struggle with memory and thinking skills decades later.
-
Plant-Based Diet Could Cut Stroke Risk
Eating a diet rich in beans, vegetables, and whole grains was beneficial in a long-term study.
-
What Causes Stroke in Young Patients?
A patient might be young, but he or she could be living with serious, unaddressed medical conditions that can lead to disaster.
-
Prednisone vs. Placebo in Short-Term Prevention of Episodic Cluster Headaches
Prednisone, given at 100 mg for five days and then tapering by 20 mg every three days, is a safe and effective short-term prevention for episodic cluster headaches while waiting for longer-acting preventive agents to be initiated.
-
Intracranial Plaque Rupture and Stroke
An MRI study of cerebral circulation in patients with embolic stroke of undetermined etiology showed evidence of atherosclerotic plaque in most patients, supporting the theory that unstable intracranial artery plaques play an etiologic role in embolic stroke.
-
COVID-19 Affected U.S. Life Expectancy: How Bad Is It?
The pandemic dinged the average, but the latest data do not tell the whole story.
-
Cognitive Benefit of Rivastigmine in Parkinson’s Disease Dementia with Orthostatic Hypotension
Individuals with Parkinson’s disease dementia and orthostatic hypotension (OH) showed more robust cognitive improvement from rivastigmine vs. those without OH. The anti-OH effect of rivastigmine probably mediates this better response.